Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STOP CLOT Trial
2021-000442-18Phase 3Active
- Sponsor
- National Institute of Cardiology
- Start
- Jun 2021
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of heparin in mitral regurgitation (MR) (2 arms), sponsored by National Institute of Cardiology. Primary endpoint: Primary composite study endpoint. Started Jun 2021; status: active.
02
Drugs
heparin
03
Conditions
mitral regurgitation (MR)
Beyond the preview
Go deeper on 2021-000442-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-000442-18.